Otsu M - Search Results

1

Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.

Ogawa S, Shih LY, Suzuki T, Otsu M, Nakauchi H, Koeffler HP, Sanada M. Ogawa S, et al. Among authors: otsu m. Clin Cancer Res. 2010 Aug 1;16(15):3825-31. doi: 10.1158/1078-0432.CCR-09-2341. Epub 2010 Jun 14. Clin Cancer Res. 2010. PMID: 20547695 Review.

2

Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.

Nabekura T, Otsu M, Nagasawa T, Nakauchi H, Onodera M. Nabekura T, et al. Among authors: otsu m. Mol Ther. 2006 Feb;13(2):301-9. doi: 10.1016/j.ymthe.2005.09.021. Epub 2005 Nov 28. Mol Ther. 2006. PMID: 16311073 Free article.

3

A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells.

Sanuki S, Hamanaka S, Kaneko S, Otsu M, Karasawa S, Miyawaki A, Nakauchi H, Nagasawa T, Onodera M. Sanuki S, et al. Among authors: otsu m. J Gene Med. 2008 Sep;10(9):965-71. doi: 10.1002/jgm.1232. J Gene Med. 2008. PMID: 18613301

4

T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera.

Sogo T, Kawahara M, Ueda H, Otsu M, Onodera M, Nakauchi H, Nagamune T. Sogo T, et al. Among authors: otsu m. Cytokine. 2009 Apr;46(1):127-36. doi: 10.1016/j.cyto.2008.12.020. Epub 2009 Feb 14. Cytokine. 2009. PMID: 19223197

5

The actin polymerization regulator WAVE2 is required for early bone marrow repopulation by hematopoietic stem cells.

Ogaeri T, Eto K, Otsu M, Ema H, Nakauchi H. Ogaeri T, et al. Among authors: otsu m. Stem Cells. 2009 May;27(5):1120-9. doi: 10.1002/stem.42. Stem Cells. 2009. PMID: 19415782

6

Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.

Okabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H. Okabe M, et al. Among authors: otsu m. Blood. 2009 Aug 27;114(9):1764-7. doi: 10.1182/blood-2009-02-203695. Epub 2009 Jun 29. Blood. 2009. PMID: 19564635 Free article.

7

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, Tamura A, Honda H, Sakata-Yanagimoto M, Kumano K, Oda H, Yamagata T, Takita J, Gotoh N, Nakazaki K, Kawamata N, Onodera M, Nobuyoshi M, Hayashi Y, Harada H, Kurokawa M, Chiba S, Mori H, Ozawa K, Omine M, Hirai H, Nakauchi H, Koeffler HP, Ogawa S. Sanada M, et al. Among authors: otsu m. Nature. 2009 Aug 13;460(7257):904-8. doi: 10.1038/nature08240. Epub 2009 Jul 20. Nature. 2009. PMID: 19620960

8

Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.

Ogawa S, Sanada M, Shih LY, Suzuki T, Otsu M, Nakauchi H, Koeffler HP. Ogawa S, et al. Among authors: otsu m. Cell Cycle. 2010 Mar 15;9(6):1051-6. doi: 10.4161/cc.9.6.11034. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237427 Free PMC article. Review.

9

Reprogramming adult hematopoietic cells.

Kaneko S, Otsu M, Nakauchi H. Kaneko S, et al. Among authors: otsu m. Curr Opin Hematol. 2010 Jul;17(4):271-5. doi: 10.1097/MOH.0b013e32833a25ee. Curr Opin Hematol. 2010. PMID: 20571391 Review.

10

Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.

Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, Yamaguchi T, Otsu M, Nishimura K, Nakanishi M, Sawaguchi A, Nagai R, Takahashi K, Yamanaka S, Nakauchi H, Eto K. Takayama N, et al. Among authors: otsu m. J Exp Med. 2010 Dec 20;207(13):2817-30. doi: 10.1084/jem.20100844. Epub 2010 Nov 22. J Exp Med. 2010. PMID: 21098095 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters